125 related articles for article (PubMed ID: 36454672)
1. DLGAP5 knockdown inactivates the Wnt/β-catenin signal to repress endometrial cancer cell malignant activities.
Chen R; Liu J; Hu J; Li C; Liu Y; Pan W
Environ Toxicol; 2023 Mar; 38(3):685-693. PubMed ID: 36454672
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NCAPG expression inactivates the Wnt/β-catenin signal to suppresses endometrial cancer cell growth in vitro.
Liu C; Yan Y; Di F; Li W; Yin X; Dong L
Environ Toxicol; 2021 Dec; 36(12):2512-2520. PubMed ID: 34480403
[TBL] [Abstract][Full Text] [Related]
3. KIF15 knockdown inhibits the development of endometrial cancer by suppressing epithelial-mesenchymal transition and stemness through Wnt/β-catenin signaling.
Huang J; Sun X; Diao G; Li R; Guo J; Han J
Environ Toxicol; 2023 Aug; 38(8):1824-1834. PubMed ID: 37186152
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
5. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.
Ni H; Ji D; Li J; Zhao Z; Zuo J
Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591
[TBL] [Abstract][Full Text] [Related]
6. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
7. RBBP4 promotes colon cancer malignant progression
Li YD; Lv Z; Zhu WF
World J Gastroenterol; 2020 Sep; 26(35):5328-5342. PubMed ID: 32994691
[TBL] [Abstract][Full Text] [Related]
8. PARG Promotes Esophagus Cancer Cell Metastasis by Activation of the Wnt/β-Catenin Pathway.
Yan J; Zhou Y; Wang Y; Liu Y
Biochem Genet; 2024 Apr; 62(2):761-774. PubMed ID: 37429965
[TBL] [Abstract][Full Text] [Related]
9. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway.
Xu Y; Hu J; Lv Q; Shi C; Qiu M; Xie L; Liu W; Yang B; Shan W; Cheng Y; Zhao B; Chen X
Stem Cell Res Ther; 2023 Jun; 14(1):159. PubMed ID: 37287079
[TBL] [Abstract][Full Text] [Related]
10. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway.
Wang F; Zhu W; Yang R; Xie W; Wang D
Mol Cell Biochem; 2019 Jun; 456(1-2):73-83. PubMed ID: 30635820
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway.
Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849
[No Abstract] [Full Text] [Related]
12. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
13. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.
Lin Y; Chen X; Lin L; Xu B; Zhu X; Lin X
Cell Mol Biol Lett; 2024 May; 29(1):63. PubMed ID: 38698330
[TBL] [Abstract][Full Text] [Related]
14. WDR34 affects PI3K/Akt and Wnt/β-catenin pathways to regulates malignant biological behaviors of glioma cells.
Zuo J; Liu C; Ni H; Yu Z
J Neurooncol; 2022 Jan; 156(2):281-293. PubMed ID: 34981299
[TBL] [Abstract][Full Text] [Related]
15. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
Moroney MR; Woodruff E; Qamar L; Bradford AP; Wolsky R; Bitler BG; Corr BR
Mol Carcinog; 2021 Aug; 60(8):511-523. PubMed ID: 34038589
[TBL] [Abstract][Full Text] [Related]
17.
Li Y; Wei J; Sun Y; Zhou W; Ma X; Guo J; Zhang H; Jin T
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958803
[TBL] [Abstract][Full Text] [Related]
18. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
[TBL] [Abstract][Full Text] [Related]
19. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
[TBL] [Abstract][Full Text] [Related]
20. RNA-Binding Protein MEX3A Interacting with DVL3 Stabilizes Wnt/β-Catenin Signaling in Endometrial Carcinoma.
Yang P; Zhang P; Zhang S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
